These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11932425)

  • 21. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin.
    Nüssler F; Clague MJ; Herrmann A
    Biophys J; 1997 Nov; 73(5):2280-91. PubMed ID: 9370425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of additional acylation site(s) of influenza B virus hemagglutinin on syncytium formation.
    Ujike M; Nakajima K; Nobusawa E
    Microbiol Immunol; 2005; 49(4):355-9. PubMed ID: 15840961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly.
    Chen BJ; Takeda M; Lamb RA
    J Virol; 2005 Nov; 79(21):13673-84. PubMed ID: 16227287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional specificity of Influenza virus haemagglutinin and paramyxovirus fusion protein anchoring peptides.
    Kordyukova L
    Virus Res; 2017 Jan; 227():183-199. PubMed ID: 27773768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.
    Chernomordik LV; Frolov VA; Leikina E; Bronk P; Zimmerberg J
    J Cell Biol; 1998 Mar; 140(6):1369-82. PubMed ID: 9508770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic tail length influences fatty acid selection for acylation of viral glycoproteins.
    Veit M; Reverey H; Schmidt MF
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):163-72. PubMed ID: 8761467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemagglutinin of Influenza A, but not of Influenza B and C viruses is acylated by ZDHHC2, 8, 15 and 20.
    Gadalla MR; Abrami L; van der Goot FG; Veit M
    Biochem J; 2020 Jan; 477(1):285-303. PubMed ID: 31872235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass spectrometric sequencing and acylation character analysis of C-terminal anchoring segment from Influenza A hemagglutinin.
    Serebryakova MV; Kordyukova LV; Baratova LA; Markushin SG
    Eur J Mass Spectrom (Chichester); 2006; 12(1):51-62. PubMed ID: 16531651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palmitoylation of influenza virus proteins.
    Veit M; Serebryakova MV; Kordyukova LV
    Biochem Soc Trans; 2013 Feb; 41(1):50-5. PubMed ID: 23356257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.
    Armstrong RT; Kushnir AS; White JM
    J Cell Biol; 2000 Oct; 151(2):425-37. PubMed ID: 11038188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin.
    Naim HY; Amarneh B; Ktistakis NT; Roth MG
    J Virol; 1992 Dec; 66(12):7585-8. PubMed ID: 1433532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.
    Melikyan GB; Lin S; Roth MG; Cohen FS
    Mol Biol Cell; 1999 Jun; 10(6):1821-36. PubMed ID: 10359599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
    Markosyan RM; Cohen FS; Melikyan GB
    Mol Biol Cell; 2000 Apr; 11(4):1143-52. PubMed ID: 10749920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology.
    Russell CJ
    Curr Top Microbiol Immunol; 2014; 385():93-116. PubMed ID: 25007844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.
    Qiao H; Armstrong RT; Melikyan GB; Cohen FS; White JM
    Mol Biol Cell; 1999 Aug; 10(8):2759-69. PubMed ID: 10436026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors determining vesicular lipid mixing induced by shortened constructs of influenza hemagglutinin.
    LeDuc DL; Shin YK; Epand RF; Epand RM
    Biochemistry; 2000 Mar; 39(10):2733-9. PubMed ID: 10704225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple local contact sites are induced by GPI-linked influenza hemagglutinin during hemifusion and flickering pore formation.
    Frolov VA; Cho MS; Bronk P; Reese TS; Zimmerberg J
    Traffic; 2000 Aug; 1(8):622-30. PubMed ID: 11208150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol promotes hemifusion and pore widening in membrane fusion induced by influenza hemagglutinin.
    Biswas S; Yin SR; Blank PS; Zimmerberg J
    J Gen Physiol; 2008 May; 131(5):503-13. PubMed ID: 18443361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.